Produktinformation
- 4-[2-[4-Formyl-5-hydroxy-6-methyl-3-[(phosphonooxy)methyl]-2-pyridinyl]diazenyl]-1,3-benzenedisulfonic Acid Tetrasodium Salt
- PPADS, Tetrasodium Salt
Stability Unstable in Aqueous Solution
Applications PPADS Tetrasodium is an non-selective purinergic antagonists of P2 ATP receptors. PPADS Tetrasodium is also a potential neuroprotective agents for the treatment of autoimmune and demyelinating disease.
References Cavaliere, F., et al.: Neurochem., 38, 189 (2001); Zona, C., et al.: Brain. Rsch., 882, 26 (2000); Lambrecht, et al.: Eur. J. Pharmacol., 217, 217 (1992); MacLaren, et al.: Br. J. Pharmacol., 111, 913 (1994);